Polar Capital Holdings’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-432,443
Closed -$8.01M 271
2025
Q3
$8.01M Buy
432,443
+222,208
+106% +$3.49M 0.04% 207
2025
Q2
$3.36M Sell
210,235
-375,516
-64% -$6.69M 0.02% 241
2025
Q1
$11.4M Buy
585,751
+136,950
+31% +$2.88M 0.07% 188
2024
Q4
$9.89M Buy
448,801
+171,404
+62% +$3.3M 0.06% 201
2024
Q3
$4.67M Buy
+277,397
New +$4.12M 0.02% 246

Other funds holding CLBT

Polar Capital Holdings's CLBT Position: Q4 2025 in Review

Polar Capital Holdings sold out of Cellebrite (CLBT) in Q4 2025, closing a stake of 432,443 shares — an estimated $8.01M sold.

Polar Capital Holdings first reported a position in CLBT in Q3 2024 and held it in 5 quarters. The position peaked at $11.4M in Q1 2025. 209 funds tracked by Wall St. Rank hold CLBT as of Q4 2025.

  • Polar Capital Holdings reported no remaining Cellebrite position as of Q4 2025 after selling out during the quarter.
  • Polar Capital Holdings sold 432,443 Cellebrite shares in Q4 2025, an estimated $8.01M.
  • Polar Capital Holdings first reported a position in Cellebrite in Q3 2024 and held it in 5 quarters.
  • Polar Capital Holdings's Cellebrite position peaked at $11.4M in Q1 2025.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q4 2025.

Based on Polar Capital Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.